Can talking therapy keep young psychosis patients in treatment?

NCT ID NCT05310838

Ongoing Knowledge-focused Sponsor: California State University, San Bernardino Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a 12-session behavioral activation program to usual care for 58 Latino individuals aged 15–35 with first-episode psychosis. The goal is to see if the program improves how actively patients engage in their own care. Researchers will measure engagement and quality of life over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Behavioral activation therapy
What this could lead to: If successful, this could point toward a simple, talk-based way to help people with early psychosis stay engaged in their care.
What could go wrong: This is a small, early-stage study with only 58 participants, so results may not apply to everyone. The intervention is behavioral, not a drug, so effects may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENGAGEMENT, PATIENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Patient Participation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ENGAGEMENT, PATIENT FIRST-EPISODE PSYCHOSIS

Contacts and locations

Show contact details

Locations

Olive View - UCLA Medical Center

Sylmar, California, 91342, United States
San Fernando Mental Health Center

Granada Hills, California, 91344, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.